High rate of EBV reactivation following allogeneic stem cell transplantation.

被引：0
|
作者：
Hebart, H
Ott, M
Wagner, S
Knecht, H
MullerKarls, N
Muller, CA
Kanz, L
Einsele, H
机构：
[1] UNIV TUBINGEN,MED KLIN,ABT 2,D-7400 TUBINGEN,GERMANY
[2] ABT VIROL,HOMBURG,GERMANY
[3] UNIV LAUSANNE,HAMATOL ABT,LAUSANNE,SWITZERLAND
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1697 / 1697
页数：1
相关论文
共 50 条
  • [1] Risk pattern of EBV-reactivation following allogeneic stem cell transplantation
    Bauhardt, A.
    Dammann, E.
    Stadler, M.
    Eder, M.
    Krauter, J.
    Ganser, A.
    Buchholz, S.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S221 - S221
  • [2] The Impact of Letermovir Prescribing on the Rate of Cytomegalovirus Reactivation Following Allogeneic Stem Cell Transplantation
    Smith, Siobhan
    Duncan, Nick
    Ricketts, Laura
    O'Neill, Jessica
    Gautama, Brijesh
    Ibrahim, Abeer
    Jones, Ceri H.
    Kempshall, Emma
    Ingram, Wendy
    Wilson, Keith
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 372 - 373
  • [3] Readmissions following allogeneic hematopoietic stem cell transplantation.
    Spring, Laura
    Li, Shuli
    Soiffer, Robert
    Alyea, Edwin
    Glotzbecker, Brett
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31)
  • [4] HIGH RATE OF EBV REPLICATION FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION - PRELIMINARY DATA OF A ROUTINE MONITORING POLICY
    Gerull, S.
    Stern, M.
    Bucher, C.
    Heim, D.
    Halter, J.
    Hirsch, H.
    Passweg, J.
    [J]. HAEMATOLOGICA, 2012, 97 : 723 - 723
  • [5] Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation.
    Peric, Zinaida
    Cahu, Xavier
    Chevallier, Patrice
    Brissot, Eolia
    Malard, Florent
    Guillaume, Thierry
    Delaunay, Jacques
    Ayari, Sameh
    Dubruille, Viviane
    Le Gouill, Steven
    Mahe, Beatrice
    Gastinne, Thomas
    Blin, Nicolas
    Saulquin, Beatrice
    Harrouseau, Jean-Luc
    Moreau, Philippe
    Milpied, Noel
    Coste-Burel, Marianne
    Imbert-Marcille, Berthe-Marie
    Mohty, Mohamad
    [J]. BLOOD, 2010, 116 (21) : 539 - 540
  • [6] Cidofovir (CDF) for the treatment of EBV-infection in allogeneic stem cell transplantation.
    Ullmann, J
    Ledderose, G
    Jaeger, G
    Kolb, HJ
    [J]. BLOOD, 2000, 96 (11) : 192A - 192A
  • [7] Alloimmune heptitis following allogeneic peripheral stem cell transplantation.
    Habib, S
    Nalesnik, MA
    Shakil, OA
    Ahmed, J
    BuchBarker, D
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 56 - 56
  • [8] Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.
    Magalhaes-Silverma, Margarida
    Parrott, Karen
    Carter, Thomas
    Leopold, Christina
    Raymond, Hohl
    Roger, Gingrich
    [J]. BLOOD, 2006, 108 (11) : 807A - 807A
  • [9] EBV-reactivation after allogeneic hematopoietic stem cell transplantation: To treat or not to treat?
    Schoemans, H.
    Theunissen, K.
    Boogaerts, M.
    Maertens, J.
    [J]. ACTA CLINICA BELGICA, 2006, 61 (02): : 114 - 114
  • [10] EBV-associated problems following allogeneic stem cell transplantation:: a study on 28 cases with lymphoproliferative disease and reactivation
    Ocheni, S.
    Kroeger, N.
    Zabelina, T.
    Erttmann, R.
    Kabisch, H.
    Zander, A.
    Bacher, U.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S275 - S275
12345